This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
497 |
4. Check minimum number of eventsNone |
497 |
5. Include endpointsNone |
497 |
6. Filter based on genotype QC (FinnGen only) |
497 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHEMOCHILD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes ticiformes
Similar endpoints
↥List of similar endpoints to
Tic disorders
based on the number of shared cases.
Similar with more cases:
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 497 | 251 | 246 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | 14.86 | 17.47 | 12.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 431
- Matched controls
- 4312
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F95.9
ICD-10 Finland
Tic disorder, unspecified
+∞
172.9
154
*
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
2218.0
162.2
147
*
F95.0
ICD-10 Finland
Transient tic disorder
1261.0
104.8
98
*
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
+∞
80.8
75
*
N05AX08
ATC
risperidone; systemic
12.4
61.4
118
127
F90.0
ICD-10 Finland
Disturbance of activity and attention
16.1
47.5
79
59
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.1
45.8
146
336
N06BA04
ATC
methylphenidate; oral
17.7
40.3
64
42
N05AX12
ATC
aripiprazole; systemic
8.7
35.2
80
110
N05AD01
ATC
haloperidol; systemic
23.4
34.9
50
24
N05AH04
ATC
quetiapine; oral
4.4
30.5
129
382
N03AE01
ATC
clonazepam; systemic
12.4
30.0
55
50
30620
ICD-8 Finland
Special symptoms not elsewhere classified, Tics
+∞
27.4
26
*
F95.8
ICD-10 Finland
Other tic disorders
+∞
25.2
24
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
7.1
24.8
63
101
F93.89
ICD-10 Finland
Other childhood emotional disorders
92.0
23.9
26
*
N06AB06
ATC
sertraline; oral
4.4
23.2
92
249
N05BA04
ATC
oxazepam; oral
3.6
22.4
119
417
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.8
20.8
100
321
N06AB03
ATC
fluoxetine; oral
4.4
20.2
78
204
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
37.8
20.0
25
7
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
8.9
20.0
43
53
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
6.9
20.0
51
82
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
9.9
19.3
39
43
N06BA09
ATC
atomoxetine; oral
+∞
18.9
18
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
7.3
18.4
45
68
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
38.5
17.8
22
6
IGP01
NOMESCO Finland
Psychiatric family contact
11.1
17.5
33
32
N05AH03
ATC
olanzapine; systemic
5.1
17.4
57
125
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
12.3
16.3
29
25
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.3
16.2
51
107
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.5
16.0
59
147
F84.5
ICD-10 Finland
Asperger syndrome
14.5
15.7
26
19
N06AX16
ATC
venlafaxine; oral
3.6
15.7
77
248
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
15.5
90
329
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
16.9
15.4
24
15
N03AX09
ATC
lamotrigine; oral
5.6
15.0
44
85
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.7
14.9
38
61
IGV01
NOMESCO Finland
Psychiatric network contact
11.0
14.9
28
27
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
+∞
14.7
14
*
N05BA01
ATC
diazepam; systemic, rectal
3.7
14.0
63
188
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
+∞
13.6
13
*
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
7.3
13.4
32
47
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
12.9
71
247
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
8.4
12.5
27
34
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
12.5
61
195
N03AG01
ATC
valproic acid; systemic, rectal
4.5
12.5
44
105
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
66.8
11.7
13
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.8
11.6
49
139
N05AG02
ATC
pimozide; oral
+∞
11.5
11
*
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
+∞
11.5
11
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.2
11.2
42
107
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.6
10.6
24
33
G24.5
ICD-10 Finland
Blepharospasm
112.6
10.5
11
*
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
+∞
10.5
10
*
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
12.5
10.4
18
15
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.8
10.4
73
295
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.3
10.4
31
62
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
33.4
10.4
13
*
N06AB10
ATC
escitalopram; oral
2.3
10.4
105
522
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.4
10.1
36
87
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.5
10.0
29
56
N06AX11
ATC
mirtazapine; oral
2.2
9.9
110
570
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
6.4
9.8
25
41
N06AB04
ATC
citalopram; systemic
2.7
9.7
70
289
N06AX12
ATC
bupropion; oral
3.3
9.6
48
156
IEV99
NOMESCO Finland
Other psychiatric network intervention
10.4
9.6
18
18
G51.3
ICD-10 Finland
Clonic hemifacial spasm
102.1
9.4
10
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.6
9.2
26
49
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.0
9.1
36
97
F83
ICD-10 Finland
Mixed specific developmental disorders
5.5
9.1
26
50
R42
ICD-10 Finland
Dizziness and giddiness
2.6
8.9
68
289
C07AA05
ATC
propranolol; systemic
2.3
8.9
85
409
F80.1
ICD-10 Finland
Expressive language disorder
6.8
8.8
21
32
RT420
NOMESCO Finland
NA
51.0
8.7
10
*
R25.3
ICD-10 Finland
Fasciculation
51.0
8.7
10
*
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
8.5
8.7
18
22
F88
ICD-10 Finland
Other disorders of psychological development
20.5
8.5
12
6
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.9
8.5
20
30
N03AF01
ATC
carbamazepine; oral, rectal
6.4
8.4
21
34
N03AX12
ATC
gabapentin; oral
3.1
8.4
47
165
SPAT1240
SPAT
Therapeutic discussion
2.3
8.4
80
384
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
+∞
8.4
8
*
F91.9
ICD-10 Finland
Conduct disorder, unspecified
+∞
8.4
8
*
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
12.0
8.1
14
12
F84.8
ICD-10 Finland
Other pervasive developmental disorders
22.5
8.0
11
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.0
154
984
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.2
7.9
40
132
N06AA04
ATC
clomipramine; systemic
9.7
7.8
15
16
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
7.8
34
100
M79.6
ICD-10 Finland
Pain in limb
1.9
7.7
123
733
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
12.1
7.6
13
11
N04AA02
ATC
biperiden; systemic
9.1
7.6
15
17
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.6
7.6
33
97
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.4
7.5
26
62
N05BE01
ATC
buspirone; oral
7.9
7.4
16
21
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.3
7.4
26
63
SPAT1307
SPAT
Psychosocial counselling and guidance
2.4
7.3
66
306
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
6.4
7.3
18
29
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
7.3
7
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
7.3
85
445
F31.8
ICD-10 Finland
Other bipolar affective disorders
7.5
7.2
16
22
SPAT1243
SPAT
Psychiatric/psychological examination
3.2
7.2
37
124
Z71.8
ICD-10 Finland
Other specified counselling
1.9
7.2
114
677
F84.0
ICD-10 Finland
Childhood autism
20.4
7.2
10
5
IEP99
NOMESCO Finland
Other psychiatric family intervention
9.0
7.1
14
16
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.5
7.0
17
27
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
6.9
96
541
M03BX01
ATC
baclofen; systemic
14.1
6.9
11
8
ICA03
NOMESCO Finland
Psychiatric treatment plan, outsourced psychotherapy
22.9
6.7
9
*
N05CF01
ATC
zopiclone; oral
2.1
6.7
75
385
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.0
6.7
14
18
N06AB05
ATC
paroxetine; oral
3.7
6.6
27
76
Z72.8
ICD-10 Finland
Other problems related to lifestyle
10.2
6.6
12
12
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
6.5
78
412
C02AC01
ATC
clonidine; systemic
70.8
6.4
7
*
F95
ICD-10 Finland
Tic disorders
70.8
6.4
7
*
N06BA12
ATC
lisdexamfetamine; oral
14.6
6.4
10
7
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
6.3
81
442
J01DB01
ATC
cefalexin; oral
1.8
6.3
325
2736
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.2
6.3
22
54
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
6.3
6
*
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
6.3
6
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
+∞
6.3
6
*
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.4
6.2
28
86
F50.9
ICD-10 Finland
Eating disorder, unspecified
5.9
6.2
16
28
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
6.1
41
164
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
12.8
6.1
10
8
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
6.0
43
178
R03AC02
ATC
salbutamol; inhalant
1.6
6.0
214
1614
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
171
871
2.47
18.95
2.7
3.1
2.4
2.4
mmol/l
0.31
150
780
381
2803
2.54
17.42
4.1
3.6
14.5
14.5
pmol/l
0.14
350
2530
124
579
2.52
16.26
2.5
1.6
1.5
1.4
%
2.17
113
534
221
1355
2.14
14.98
2.6
2.6
68.3
70.2
nmol/l
0.46
213
1256
166
937
2.16
13.69
1.9
1.6
101.2
99.4
pmol/l
0.21
92
473
412
3305
2.44
12.94
5.1
4.1
1.9
1.9
mu/l
0.19
393
3085
321
2349
2.04
12.60
7.1
6.3
86.6
84.6
u/l
0.25
304
2201
380
2967
2.19
12.42
3.8
2.9
5.6
5.6
mmol/l
0.31
359
2725
184
1118
2.03
12.20
3.4
3.2
27.9
32.5
u/l
1.94
174
1066
132
714
2.16
11.91
2.9
2.1
169.3
361.2
u/l
1.10
124
674
92
428
2.41
11.88
1.5
1.6
426.9
17632024.1
pmol/l
0.50
79
380
426
3512
2.49
11.83
14.4
10.8
139.6
139.5
mmol/l
0.06
421
3384
105
520
2.29
11.75
1.6
1.3
18.3
20.4
nmol/l
0.99
94
453
426
3523
2.46
11.55
14.5
10.7
3.9
3.9
mmol/l
0.09
420
3383
332
2500
1.99
11.50
4.3
3.7
8.6
8.2
mm/h
0.25
306
2309
218
1443
1.91
10.99
8.1
7.6
1.2
1.2
mmol/l
0.14
188
1248
216
1435
1.89
10.69
6.1
5.9
10.0
11.0
umol/l
1.29
206
1346
74
343
2.36
9.55
1.6
1.7
1163.3
1150.6
nmol/l
0.04
61
266
177
1141
1.86
9.34
5.0
6.0
38.0
37.7
g/l
0.29
166
1073
89
450
2.19
9.34
6.2
6.5
0.8
0.8
mmol/l
0.81
82
427
143
896
1.84
8.08
2.8
2.5
52.4
57.4
u/l
0.54
133
831
194
1338
1.74
7.87
7.1
7.5
1.2
1.2
mmol/l
0.03
179
1241
293
2274
1.70
7.61
10.4
9.5
3.7
3.9
e9/l
0.68
257
1974
316
2504
1.72
7.59
4.1
2.9
30.6
32.6
u/l
0.41
301
2400
164
1108
1.72
7.01
3.3
3.5
—
—
—
0
0
22
68
3.34
6.07
1.6
1.6
—
—
—
0
0
440
3943
2.01
5.89
10.6
8.0
27.7
27.6
u/l
0.05
431
3805
11
20
5.60
5.83
1.3
2.6
11.0
17.1
umol/l
1.05
11
20
127
841
1.69
5.68
3.7
2.9
32.7
39.7
ng/l
0.15
65
396
15
37
4.15
5.66
1.0
1.1
—
—
—
0
0
233
1790
1.57
5.66
3.1
2.9
78.0
73.4
ug/l
0.22
219
1683
123
831
1.64
5.03
3.0
2.7
2.7
2.7
mg/l
0.09
108
703
363
3129
1.59
4.99
3.5
3.1
4.5
4.6
mmol/l
1.21
349
2957
352
3021
1.57
4.85
12.9
8.5
100.7
100.3
ml/min/173m2
0.10
286
2272
239
1897
1.50
4.72
4.5
4.9
6.2
6.4
mmol/l
0.64
218
1716
362
3139
1.56
4.65
3.7
3.3
2.7
2.8
mmol/l
0.52
345
2941
358
3106
1.55
4.49
3.4
3.1
1.4
1.4
mmol/l
0.85
340
2930
310
2613
1.50
4.44
4.3
3.9
37.0
37.5
mmol/mol
0.37
296
2477
38
188
2.11
4.21
1.9
1.7
—
—
—
0
0
212
1675
1.46
4.11
4.6
4.5
0.0
0.0
estimate
0.00
47
344
66
400
1.75
4.01
3.0
2.8
2.4
2.4
mmol/l
0.13
59
346
129
927
1.53
3.97
3.4
3.3
0.3
0.2
e6/l
0.33
97
695
17
59
2.95
3.93
1.2
1.5
—
—
—
0
0
55
318
1.82
3.91
2.1
2.5
188.6
32.2
u/l
0.47
47
263
212
1694
1.44
3.79
3.5
3.2
0.0
0.0
estimate
0.00
45
328
427
3908
1.66
3.77
14.2
10.2
18.9
22.0
mg/l
1.57
319
2821
47
262
1.88
3.75
5.2
5.9
—
—
—
0
0
167
1284
1.45
3.64
1.5
1.5
0.6
1.6
u/ml
1.89
38
290
9
17
5.37
3.52
3.2
7.4
16.7
19.6
ug/l
—
9
17
119
865
1.49
3.43
3.1
3.4
0.0
0.0
estimate
0.50
45
334
207
1674
1.41
3.36
3.4
3.2
0.0
0.0
estimate
0.00
45
331
338
2974
1.43
3.34
3.3
2.9
1.2
1.2
mmol/l
0.02
322
2806
477
4540
2.26
3.32
20.8
14.7
137.5
137.8
g/l
0.19
471
4484
13
43
3.08
3.27
1.0
1.1
—
—
—
0
0
63
400
1.66
3.25
1.1
1.1
—
—
—
0
0
35
186
1.95
3.24
1.6
1.7
—
—
—
0
0
8
15
5.40
3.20
1.0
1.2
—
—
—
0
0
8
15
5.40
3.20
1.0
1.2
—
—
—
0
0
45
262
1.79
3.16
2.1
1.7
—
—
—
0
0
78
527
1.57
3.13
3.4
3.0
1.9
3.0
e6/l
1.04
49
281
72
479
1.59
3.09
7.4
7.8
1.1
1.2
mmol/l
0.68
67
452
48
293
1.71
2.88
1.3
1.4
235.6
350.8
u/ml
0.53
43
270
59
384
1.61
2.78
4.2
4.0
9.0
7.1
umol/l
0.17
50
319
7
14
5.05
2.73
1.0
1.3
—
—
—
0
0
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
101
745
1.45
2.67
1.7
1.6
1.5
1.4
mmol/l
0.65
87
662
78
548
1.50
2.63
3.4
2.9
0.6
0.7
e6/l
0.39
49
298
26
135
1.98
2.60
1.6
1.6
—
—
—
0
0
65
440
1.55
2.60
1.8
1.8
—
—
—
0
0
51
326
1.63
2.59
5.9
6.3
1.2
1.1
mmol/l
0.07
34
238
388
3560
1.41
2.57
17.4
12.8
13.2
13.2
%
0.20
382
3496
12
44
2.77
2.56
1.1
1.1
—
—
—
0
0
11
39
2.86
2.49
1.1
1.2
—
—
—
0
0
71
497
1.50
2.44
1.3
1.2
18.8
26.9
iu/ml
0.41
17
151
16
70
2.33
2.43
1.3
1.2
—
—
—
0
0
35
206
1.75
2.41
5.8
15.0
1.1
1.2
inr
—
8
43
51
333
1.59
2.39
6.0
6.2
5.2
5.1
kpa
0.73
45
313
5
8
6.30
2.37
1.2
1.0
8.6
18.4
u/l
—
5
8
46
294
1.62
2.35
1.8
1.7
—
—
—
0
0
46
301
1.58
2.15
1.8
1.7
—
—
—
0
0
43
277
1.60
2.14
3.2
3.0
31.9
31.2
%
0.12
30
198
65
460
1.48
2.13
3.3
3.8
494.0
1340.8
ng/l
1.47
54
357
8
25
3.23
2.10
1.0
1.2
—
—
—
0
0
154
1266
1.31
2.05
3.3
3.1
—
—
—
0
0
8
26
3.11
2.02
1.0
1.1
—
—
—
0
0
50
339
1.53
2.01
1.2
1.2
135.9
126.5
iu/ml
0.07
16
115
61
432
1.47
2.00
4.4
7.1
2.0
1.6
mmol/l
0.59
50
340
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
31
190
1.67
1.89
3.8
4.5
1.2
1.2
mmol/l
0.56
25
169
72
534
1.41
1.86
4.2
4.6
12.1
14.6
mg/mmol
0.14
49
379
5
12
4.20
1.82
1.0
1.2
—
—
—
0
0
92
714
1.35
1.81
3.1
2.7
1.1
1.0
mg/l
0.10
57
496
8
29
2.79
1.80
1.1
1.0
266.9
301.5
mg/l
—
8
23
10
41
2.47
1.76
1.3
1.5
—
—
—
0
0
10
42
2.41
1.68
1.1
1.1
—
—
—
0
0
38
254
1.54
1.66
1.5
1.3
199.1
271.5
miu/ml
0.55
12
132
37
247
1.54
1.63
3.6
2.8
—
—
—
0
0
51
366
1.44
1.59
3.8
2.6
2866.4
5334.0
u/l
0.47
17
151
420
3991
1.34
1.56
14.6
11.2
40.6
40.8
%
0.17
336
3427
65
492
1.37
1.51
3.2
2.9
76.3
910.3
ng/l
2.06
29
281
5
16
3.15
1.44
2.2
2.6
—
—
—
0
0
13
236
0.54
1.41
1.8
1.6
—
—
—
0
0
27
174
1.58
1.40
1.3
1.6
331.4
170.3
u/ml
1.12
13
101
17
98
1.76
1.32
1.3
1.2
—
—
—
0
0
31
210
1.51
1.31
1.1
1.2
4.0
1.8
u/ml
0.47
19
122
62
478
1.34
1.30
1.3
1.2
11.4
6.9
u/ml
0.23
24
196
12
217
0.54
1.29
1.7
1.8
—
—
—
0
0
9
45
2.02
1.24
1.1
4.2
—
—
—
0
0
14
79
1.79
1.18
1.5
1.4
—
—
—
0
0
8
39
2.07
1.15
1.3
1.3
—
—
—
0
0
8
39
2.07
1.15
1.3
1.3
—
—
—
0
0
140
1215
1.21
1.12
3.3
2.3
—
—
—
0
0
8
40
2.02
1.12
1.1
4.5
33.3
27.7
%
—
8
40
8
40
2.02
1.12
1.3
1.3
—
—
—
0
0
18
112
1.63
1.10
1.1
1.1
1.6
7.9
u/ml
2.56
11
62
20
130
1.56
1.04
1.1
1.1
2.5
9.1
u/ml
1.89
11
65
89
743
1.24
1.04
2.8
2.2
—
—
—
0
0
26
180
1.47
1.03
1.3
1.5
—
—
—
0
0
25
173
1.47
0.99
1.4
1.8
3.0
2.9
mg/l
0.06
18
108
5
23
2.19
0.98
2.4
2.9
741.4
961.3
u/ml
—
5
23
41
312
1.34
0.97
7.0
7.5
105.4
104.2
mmol/l
0.94
41
307
9
51
1.78
0.95
1.6
1.1
—
—
—
0
0
6
27
2.24
0.93
1.3
1.2
338.0
168.6
iu/ml
—
6
27
18
118
1.55
0.92
1.7
2.1
40.9
41.0
u/l
0.01
18
110
33
246
1.37
0.90
1.7
1.9
10.1
13.5
iu/l
0.55
24
182
6
29
2.08
0.89
1.0
1.3
—
—
—
0
0
16
103
1.57
0.88
1.3
2.5
—
—
—
0
0
20
137
1.48
0.85
3.0
3.2
0.1
0.1
e6/l
0.04
20
130
6
31
1.95
0.84
1.8
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
10
58
1.74
0.80
1.1
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
5.5
—
37.3
—
0
6
23
165
1.41
0.79
1.4
1.4
—
—
—
0
0
7
123
0.56
0.79
1.4
1.9
—
—
—
0
0
35
447
0.77
0.78
1.2
1.4
—
—
—
0
0
37
469
0.77
0.78
1.5
1.5
—
—
—
0
0
170
1545
1.15
0.77
2.2
1.9
—
—
—
0
0
26
192
1.37
0.76
1.5
1.4
—
—
—
0
0
20
141
1.44
0.75
3.7
4.4
7.4
6.1
ug/l
0.09
15
110
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
16
108
1.50
0.74
1.7
1.9
—
—
—
0
0
17
117
1.47
0.72
1.1
1.1
—
—
—
0
0
19
134
1.43
0.72
1.0
1.1
—
—
—
0
0
7
40
1.76
0.71
1.3
1.3
—
—
—
0
0
9
57
1.59
0.71
1.1
2.5
—
—
—
0
0
7
41
1.72
0.70
1.3
1.3
—
—
—
0
0
7
41
1.72
0.70
1.3
1.3
—
—
—
0
0
21
153
1.39
0.68
3.7
3.1
64.9
125.1
ng/l
1.61
14
134
13
190
0.68
0.66
1.3
1.5
—
—
—
0
0
5
28
1.79
0.66
1.4
1.3
—
—
—
0
0
12
78
1.55
0.66
2.1
1.4
—
—
—
0
0
19
137
1.40
0.65
1.0
1.2
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
5
30
1.67
0.61
1.8
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
26
201
1.31
0.60
8.4
13.8
1.1
1.1
mg/l
0.17
26
193
14
97
1.46
0.59
2.7
2.0
3.0
7.4
iu/l
—
6
33
10
64
1.57
0.59
2.0
1.9
—
—
—
0
0
10
64
1.57
0.59
1.7
1.5
—
—
—
0
0
13
89
1.47
0.58
1.6
1.3
—
—
—
0
0
13
89
1.47
0.58
1.6
1.3
—
—
—
0
0
16
118
1.37
0.50
1.8
1.9
—
—
—
0
0
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
142
1311
1.12
0.50
3.4
2.5
—
—
—
0
0
7
46
1.53
0.48
1.4
1.5
—
—
—
0
0
23
186
1.25
0.41
1.6
2.6
86.7
82.1
ml/min/173m2
—
9
68
69
619
1.13
0.40
2.7
2.1
—
—
—
0
0
25
205
1.23
0.40
1.3
1.2
—
—
—
0
0
5
35
1.43
0.39
1.6
1.6
—
—
—
0
0
5
36
1.39
0.38
1.0
1.2
26.8
18.0
u/l
—
5
31
6
42
1.43
0.35
3.0
1.4
—
—
—
0
0
14
108
1.30
0.35
1.1
1.1
—
—
—
0
0
41
358
1.16
0.35
1.2
1.3
—
—
—
0
0
14
112
1.26
0.28
1.0
1.0
0.1
0.8
u/ml
—
5
44
27
233
1.17
0.28
9.0
9.6
0.6
0.8
mmol/l
0.16
21
180
86
801
1.09
0.27
2.5
2.4
—
—
—
0
0
22
187
1.18
0.27
10.0
10.9
123.0
125.2
g/l
0.21
22
179
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
9
73
1.24
0.25
1.2
2.2
—
—
—
0
0
18
151
1.20
0.25
1.1
1.1
—
8.7
—
0
26
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
27.8
—
0
11
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
20
227
0.88
0.18
1.6
1.4
—
—
—
0
0
7
58
1.21
0.18
2.0
1.9
—
—
—
0
0
23
258
0.89
0.18
1.6
1.5
—
—
—
0
0
23
205
1.13
0.17
1.4
1.4
—
—
—
0
0
5
69
0.72
0.17
1.0
1.4
18.3
14.2
u/l
—
5
62
38
350
1.09
0.17
2.5
2.3
15.3
13.4
nmol/l
0.40
32
314
12
101
1.19
0.16
1.8
1.6
—
—
—
0
0
22
198
1.12
0.14
1.3
1.3
—
—
—
0
0
28
259
1.09
0.12
1.7
2.0
5.4
6.3
u/l
0.46
22
189
11
95
1.16
0.11
1.3
1.5
—
—
—
0
0
383
3797
1.04
0.11
4.1
3.8
—
—
—
0
0
37
349
1.07
0.10
3.2
3.2
20.1
22.5
%
—
9
119
21
228
0.92
0.10
1.6
1.4
—
—
—
0
0
5
44
1.14
0.10
2.2
1.6
—
—
—
0
0
5
47
1.06
0.09
2.8
1.5
—
—
—
0
0
21
227
0.92
0.09
1.6
1.4
—
—
—
0
0
21
227
0.92
0.09
1.6
1.4
—
—
—
0
0
6
54
1.11
0.09
2.3
1.9
—
—
—
0
0
6
56
1.07
0.08
2.2
1.9
—
—
—
0
0
28
297
0.94
0.08
1.5
1.4
—
—
—
0
0
64
619
1.04
0.08
1.6
1.5
—
—
—
0
0
9
86
1.05
0.07
1.8
1.8
—
—
—
0
0
23
243
0.94
0.05
2.1
1.9
—
—
—
0
0
11
119
0.92
0.04
1.3
1.2
—
—
—
0
0
26
269
0.96
0.02
3.4
2.3
0.7
0.7
ug/l
0.01
14
134
12
114
1.05
0.00
6.0
4.3
55.8
52.2
%
0.19
12
114
12
123
0.98
0.00
1.2
1.3
—
—
—
0
0
11
111
0.99
0.00
5.2
4.3
24.6
24.6
mmol/l
0.00
11
106
153
1526
1.00
0.00
4.3
3.9
—
—
—
0
0
5
50
1.00
0.00
1.4
1.2
—
—
—
0
0
5
56
0.89
0.00
1.6
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
7.4
—
0
8
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
5
56
0.89
0.00
1.6
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
8
87
0.92
0.00
1.9
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
5
54
0.93
0.00
3.2
1.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_TIC – Tic disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).